2024
COVID-19 Breakthrough Infection after Vaccination and Substance Use Disorders: A Longitudinal Cohort of People with and without HIV Receiving Care in the United States Veterans Health Administration
Soyer E, McGinnis K, Justice A, Hsieh E, Rodriguez-Barradas M, Williams E, Park L. COVID-19 Breakthrough Infection after Vaccination and Substance Use Disorders: A Longitudinal Cohort of People with and without HIV Receiving Care in the United States Veterans Health Administration. AIDS And Behavior 2024, 28: 3605-3614. PMID: 39046612, DOI: 10.1007/s10461-024-04449-1.Peer-Reviewed Original ResearchHIV statusSubstance use disordersBreakthrough infectionRisk of breakthroughAssociated with increased riskCOVID-19 breakthrough infectionsSARS-CoV-2Association of substance useSARS-CoV-2 infectionHIV treatment adherenceCD4 countHIV progressionSubstance useUnited States Veterans Health AdministrationHazard ratioIncreased riskPWHCD4PWoHHIVUse disorderVaccinated personsCohort of peopleTreatment adherenceLongitudinal cohort
2020
Incidence and Presentation of Sarcoidosis With and Without HIV Infection
Hanberg JS, Akgün K, Hsieh E, Fraenkel L, Justice A. Incidence and Presentation of Sarcoidosis With and Without HIV Infection. Open Forum Infectious Diseases 2020, 7: ofaa441. PMID: 33123611, PMCID: PMC7576681, DOI: 10.1093/ofid/ofaa441.Peer-Reviewed Original ResearchVeterans Aging Cohort StudyIncident sarcoidosisCD4 countCohort studyMedian CD4 countPresentation of sarcoidosisHIV-negative controlsAging Cohort StudyDiagnosis of sarcoidosisDevelopment of sarcoidosisHIV-1 RNAProspective observational analysisTreatment of sarcoidosisLongitudinal cohort studyIncidence of sarcoidosisRisk of sarcoidosisOral glucocorticoidsUninfected veteransUnsuppressed viremiaChart reviewOrgan involvementHIV infectionPersistent viremiaViral loadCase report